enterogastrone

was MH 1975-92 (see under GASTROINTESTINAL HORMONES 1975-90); use GASTROINTESTINAL HORMONES to search ENTEROGASTRONE 1975-92; postulated gastrointestinal hormone secreted mainly by the duodenum in the presence of fats; it inhibits both motility & acid secretion in the stomach

Networked: 41 relevant articles (0 outcomes, 4 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Marks, Vincent: 2 articles (01/2020 - 12/2019)
2.	Konturek, S J: 1 article (04/2011)

Related Diseases

1.	Peptic Ulcer (Peptic Ulcers) 07/26/1951 - "[Enterogastrone; experimental and clinical studies of its effect of peptic ulcer]." 12/01/1958 - "[Results obtained in the treatment of 104 gastroduodenal ulcer patients with enterogastrone]." 01/01/1958 - "[Enterogastrone in the treatment of gastroduodenal ulcers]." 12/01/1952 - "[Enterogastrone and folliculin in the treatment of peptic ulcer and associated syndromes]." 03/01/1952 - "Enterogastrone; experimental and clinical examinations of its effects on peptic ulcers."
2.	Duodenal Ulcer (Curling's Ulcer) 02/29/1952 - "[Enterogastrone in the treatment of duodenal ulcer]." 10/23/1948 - "Enterogastrone in the treatment of patients with duodenal ulcer." 03/01/1947 - "The effect of enterogastrone on fasting gastric secretion and motility in patients with duodenal ulcers." 11/01/1946 - "The effect of enterogastrone on fasting gastric secretion and motility in duodenal ulcer patients." 05/01/1950 - "Observations on the gastric secretion in two duodenal ulcer patients during the prolonged injections of an enterogastrone concentrate."
3.	Disease Progression 02/01/1950 - "A study of the effect of an orally administered enterogastrone preparation on the clinical course of patients with duodenal ulcer."
4.	Pancreatitis 03/01/1975 - "Secretin has undergone trials as therapy in peptic ulcer whereas glucagon is under investigation for the treatment of acute pancreatitis because of its dual actions as (1) an enterogastrone and (2) an inhibitor of pancreatic secretion."
5.	Ulcer 10/01/1949 - "Failure of an enterogastrone preparation to inhibit gastric secretion and prevent ruminal ulcers in the rat." 08/01/1947 - "Effect of enterogastrone on Mann-Williamson ulcers in dogs." 02/01/1947 - "Failure of enterogastrone to prevent rumenal ulcers in the Shay rat." 01/01/1947 - "Comparison of the anti-ulcer activity of enterogastrone and urinary anthelones." 01/01/1947 - "A method for determining the ulcer-preventive factor in enterogastrone concentrates."

Related Drugs and Biologics

1.	Epidermal Growth Factor (EGF)
2.	Secretin
3.	Glucagon (Glukagon)
4.	Cholecystokinin (Pancreozymin)
5.	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)
6.	Oxyntomodulin
7.	Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)
8.	Vitamin B 12 (Cyanocobalamin)
9.	Somatostatin (Somatotropin Release-Inhibiting Factor)
10.	Gonadal Steroid Hormones (Sex Hormones)

Related Therapies and Procedures

1.	Therapeutics
2.	Truncal Vagotomy
3.	Injections